The 36-month beta value for NRSN is also noteworthy at 1.48. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for NRSN is 14.16M, and at present, short sellers hold a 0.99% of that float. The average trading volume of NRSN on September 03, 2024 was 342.86K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
NRSN) stock’s latest price update
The stock of NeuroSense Therapeutics Ltd (NASDAQ: NRSN) has increased by 17.11 when compared to last closing price of 0.76.Despite this, the company has seen a gain of 7.23% in its stock price over the last five trading days. prnewswire.com reported 2024-08-30 that CAMBRIDGE, Mass., Aug. 30, 2024 /PRNewswire/ — NeuroSense Therapeutics Ltd.
NRSN’s Market Performance
NeuroSense Therapeutics Ltd (NRSN) has experienced a 7.23% rise in stock performance for the past week, with a 30.88% rise in the past month, and a -17.59% drop in the past quarter. The volatility ratio for the week is 15.48%, and the volatility levels for the past 30 days are at 13.29% for NRSN. The simple moving average for the past 20 days is 20.70% for NRSN’s stock, with a -20.50% simple moving average for the past 200 days.
NRSN Trading at 5.44% from the 50-Day Moving Average
After a stumble in the market that brought NRSN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -61.80% of loss for the given period.
Volatility was left at 13.29%, however, over the last 30 days, the volatility rate increased by 15.48%, as shares surge +20.56% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.11% lower at present.
During the last 5 trading sessions, NRSN rose by +7.23%, which changed the moving average for the period of 200-days by +78.36% in comparison to the 20-day moving average, which settled at $0.7450. In addition, NeuroSense Therapeutics Ltd saw 13.38% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for NRSN
The total capital return value is set at 4.1. Equity return is now at value -602.40, with -377.38 for asset returns.
Based on NeuroSense Therapeutics Ltd (NRSN), the company’s capital structure generated -0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 0.03. The debt to equity ratio resting at -0.01. The interest coverage ratio of the stock is -5.99.
Currently, EBITDA for the company is -13.21 million with net debt to EBITDA at 0.07. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.26.
Conclusion
In summary, NeuroSense Therapeutics Ltd (NRSN) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
